4//SEC Filing
Tehrani Ali 4
Accession 0000899243-20-010693
CIK 0001403752other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 9:16 PM ET
Size
8.2 KB
Accession
0000899243-20-010693
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Tehrani Ali
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-04-13−1,000→ 57,660 totalExercise: $3.85From: 2013-01-01Exp: 2022-01-01→ Common Shares (1,000 underlying) - Exercise/Conversion
Common Shares
2020-04-13$3.85/sh+1,000$3,854→ 257,009 total
Holdings
- 59,861(indirect: By Spouse)
Common Shares
Footnotes (2)
- [F1]The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $3.8535 using the Bank of Canada exchange rate for April 13, 2020 (CAD1.00 = $0.7176).
- [F2]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of January 1, 2012 and (ii) remainder of underlying shares in 36 equal monthly installments on the last day of month following first anniversary of grant date.
Documents
Issuer
Zymeworks Inc.
CIK 0001403752
Entity typeother
Related Parties
1- filerCIK 0001761853
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 9:16 PM ET
- Size
- 8.2 KB